GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Medicine Co Ltd (SHSE:600216) » Definitions » Revenue

Zhejiang Medicine Co (SHSE:600216) Revenue : ¥9,030 Mil (TTM As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Zhejiang Medicine Co Revenue?

Zhejiang Medicine Co's revenue for the three months ended in Sep. 2024 was ¥2,707 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ¥9,030 Mil. Zhejiang Medicine Co's Revenue per Share for the three months ended in Sep. 2024 was ¥2.75. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥9.49.

Good Sign:

Zhejiang Medicine Co Ltd has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Zhejiang Medicine Co was 18.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 2.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Zhejiang Medicine Co's highest 3-Year average Revenue per Share Growth Rate was 38.40% per year. The lowest was -8.70% per year. And the median was 8.70% per year.


Zhejiang Medicine Co Revenue Historical Data

The historical data trend for Zhejiang Medicine Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Medicine Co Revenue Chart

Zhejiang Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,043.93 7,326.94 9,129.09 8,115.81 7,794.15

Zhejiang Medicine Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,938.58 1,917.63 2,249.16 2,156.30 2,707.34

Competitive Comparison of Zhejiang Medicine Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Medicine Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Medicine Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Medicine Co's Revenue distribution charts can be found below:

* The bar in red indicates where Zhejiang Medicine Co's Revenue falls into.



Zhejiang Medicine Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥9,030 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Medicine Co  (SHSE:600216) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Zhejiang Medicine Co Revenue Related Terms

Thank you for viewing the detailed overview of Zhejiang Medicine Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Medicine Co Business Description

Traded in Other Exchanges
N/A
Address
Comprehensive Building, No. 398 Mahuan Road, 3rd Floor, Building A, Binhai New City, Shaoxing, CHN, 312366
Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.
Executives
Zhu Jin Lin senior management
Chu Zhen Hua Director
Liang Bi Rong Director
Yu Yu Qing Director
Ping Jian Hong senior management
An Yong Bin senior management
Wang Xiao Ping senior management
Liang Li Ping senior management
Li Qi Rong senior management
Zhu Shao Ming Supervisors
Wang Hong Wei senior management
Zhang Ding Feng senior management
Ma Wen Xin Director
Zhao Jun Xing senior management
Lv Yong Hui Director

Zhejiang Medicine Co Headlines

No Headlines